Meanwhile, the increase in plasma S100A9 level was significantly reduced in the EHW-administered group (p = 0.0071, two-way ANOVA followed by Bonferroni’s multiple comparison procedure), further supporting the anti-inflammatory effect of EHW in IBD pathophysiology. Here, S100A9 is linked to inflammatory bowel disease.